These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 22197388)
21. Synthesis and in vitro evaluation of derivatives of the β₁-adrenergic receptor antagonist HX-CH 44. Stephenson KA; Wilson AA; Houle S; Vasdev N Bioorg Med Chem Lett; 2011 Sep; 21(18):5506-9. PubMed ID: 21783363 [TBL] [Abstract][Full Text] [Related]
22. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists. Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. Gitto R; Ferro S; Agnello S; De Luca L; De Sarro G; Russo E; Vullo D; Supuran CT; Chimirri A Bioorg Med Chem; 2009 May; 17(10):3659-64. PubMed ID: 19398204 [TBL] [Abstract][Full Text] [Related]
24. Design of 1-substituted 2-arylmethyl-4,5-methylenedioxybenzene derivatives as antiseizure agents. Micale N; De Sarro G; Ferreri G; Zappalá M; Grasso S; Puia G; De Micheli C Bioorg Med Chem; 2004 Jul; 12(13):3703-9. PubMed ID: 15186856 [TBL] [Abstract][Full Text] [Related]
25. Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy. Russo E; Citraro R; De Fazio S; Marra R; Gitto R; Chimirri A; De Sarro G; Di Paola ED Epilepsy Behav; 2008 Aug; 13(2):295-9. PubMed ID: 18514580 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and anticonvulsant properties of tetrahydroisoquinoline derivatives. Gitto R; Caruso R; Orlando V; Quartarone S; Barreca ML; Ferreri G; Russo E; De Sarro G; Chimirri A Farmaco; 2004 Jan; 59(1):7-12. PubMed ID: 14751310 [TBL] [Abstract][Full Text] [Related]
27. Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. Gitto R; Caruso R; Pagano B; De Luca L; Citraro R; Russo E; De Sarro G; Chimirri A J Med Chem; 2006 Sep; 49(18):5618-22. PubMed ID: 16942035 [TBL] [Abstract][Full Text] [Related]
28. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands. Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticonvulsant activity of N-3 substituted 2,3-benzodiazepines. Quartarone S; Caruso R; Orlando V; Russo E; De Sarro G; Chimirri A Farmaco; 2004 May; 59(5):353-8. PubMed ID: 15120314 [TBL] [Abstract][Full Text] [Related]
30. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist. Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460 [TBL] [Abstract][Full Text] [Related]
31. Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists. Barreca ML; Gitto R; Quartarone S; De Luca L; De Sarro G; Chimirri A J Chem Inf Comput Sci; 2003; 43(2):651-5. PubMed ID: 12653534 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and anticonvulsant activity of new 2,3-benzodiazepines as AMPA receptor antagonists. De Sarro A; De Sarro G; Gitto R; Grasso S; Micale N; Zappalà M Farmaco; 1999 Mar; 54(3):178-87. PubMed ID: 10371031 [TBL] [Abstract][Full Text] [Related]
33. Design and development of 2,3-benzodiazepine (CFM) noncompetitive AMPA receptor antagonists. Gitto R; Zappal M; De SG; Chimirri A Farmaco; 2002 Feb; 57(2):129-34. PubMed ID: 11902655 [TBL] [Abstract][Full Text] [Related]
34. Anticonvulsant and toxicity evaluation of some 7-alkoxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline-1(2H)-ones. Jin HG; Sun XY; Chai KY; Piao HR; Quan ZS Bioorg Med Chem; 2006 Oct; 14(20):6868-73. PubMed ID: 16843667 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones. Kamiński K; Obniska J Bioorg Med Chem; 2008 May; 16(9):4921-31. PubMed ID: 18375131 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents. Amin KM; Rahman DE; Al-Eryani YA Bioorg Med Chem; 2008 May; 16(10):5377-88. PubMed ID: 18467106 [TBL] [Abstract][Full Text] [Related]
37. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity. Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD J Med Chem; 1996 May; 39(11):2232-44. PubMed ID: 8667366 [TBL] [Abstract][Full Text] [Related]